Your browser doesn't support javascript.
loading
Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model.
Broquet, Alexis; Jacqueline, Cédric; Davieau, Marion; Besbes, Anissa; Roquilly, Antoine; Martin, Jérôme; Caillon, Jocelyne; Dumoutier, Laure; Renauld, Jean-Christophe; Heslan, Michèle; Josien, Régis; Asehnoune, Karim.
Affiliation
  • Broquet A; Laboratoire UPRES EA3826 « Thérapeutiques cliniques et expérimentales des infections ¼, IRS2 - Nantes Biotech, Université de Nantes, Nantes, France.
  • Jacqueline C; Laboratoire UPRES EA3826 « Thérapeutiques cliniques et expérimentales des infections ¼, IRS2 - Nantes Biotech, Université de Nantes, Nantes, France.
  • Davieau M; Laboratoire UPRES EA3826 « Thérapeutiques cliniques et expérimentales des infections ¼, IRS2 - Nantes Biotech, Université de Nantes, Nantes, France.
  • Besbes A; Laboratoire UPRES EA3826 « Thérapeutiques cliniques et expérimentales des infections ¼, IRS2 - Nantes Biotech, Université de Nantes, Nantes, France.
  • Roquilly A; Laboratoire UPRES EA3826 « Thérapeutiques cliniques et expérimentales des infections ¼, IRS2 - Nantes Biotech, Université de Nantes, Nantes, France.
  • Martin J; CHU Nantes, Pôle anesthésie réanimations, Service d'anesthésie réanimation chirurgicale, Hôtel Dieu, Nantes, F-44093, France.
  • Caillon J; Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France.
  • Dumoutier L; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.
  • Renauld JC; Laboratoire d'Immunologie, CHU Nantes, Nantes, France.
  • Heslan M; Laboratoire UPRES EA3826 « Thérapeutiques cliniques et expérimentales des infections ¼, IRS2 - Nantes Biotech, Université de Nantes, Nantes, France.
  • Josien R; Ludwig Institute for cancer Research and Institut de Duve, Université Catholique de Louvain, B-1200, Brussels, Belgium.
  • Asehnoune K; Ludwig Institute for cancer Research and Institut de Duve, Université Catholique de Louvain, B-1200, Brussels, Belgium.
Sci Rep ; 7(1): 11010, 2017 09 08.
Article in En | MEDLINE | ID: mdl-28887540
ABSTRACT
Pseudomonas aeruginosa is a major threat for immune-compromised patients. Bacterial pneumonia can induce uncontrolled and massive neutrophil recruitment ultimately leading to acute respiratory distress syndrome and epithelium damage. Interleukin-22 plays a central role in the protection of the epithelium. In this study, we aimed to evaluate the role of interleukin-22 and its soluble receptor IL-22BP in an acute Pseudomonas aeruginosa pneumonia model in mice. In this model, we noted a transient increase of IL-22 during Pseudomonas aeruginosa challenge. Using an antibody-based approach, we demonstrated that IL-22 neutralisation led to increased susceptibility to infection and to lung damage correlated with an increase in neutrophil accumulation in the lungs. On the contrary, rIL-22 administration or IL-22BP neutralisation led to a decrease in mouse susceptibility and lung damage associated with a decrease in neutrophil accumulation. This study demonstrated that the IL-22/IL-22BP system plays a major role during Pseudomonas aeruginosa pneumonia by moderating neutrophil accumulation in the lungs that ultimately leads to epithelium protection.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas Infections / Interleukins / Receptors, Interleukin / Pneumonia, Bacterial / Neutrophil Infiltration / Lung Limits: Animals Language: En Journal: Sci Rep Year: 2017 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas Infections / Interleukins / Receptors, Interleukin / Pneumonia, Bacterial / Neutrophil Infiltration / Lung Limits: Animals Language: En Journal: Sci Rep Year: 2017 Type: Article Affiliation country: France